Atrial Fibrillatio
Conditions
Interventions
propofol group:propofol
remimazolam and flumazenil group:remimazolam and flumazenil
Sponsors
Department of Cardiovasology Changhai Hospital Naval Medical University Shanghai
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1.planned to receive electrical cardioversion 2. age =18 years 3. subjects are willing to sign an informed consent to participate in this trial.
Exclusion criteria
Exclusion criteria: ASA grade IV; 1.history of epilepsy; 2.long-term benzodiazepines history;3.myasthenia gravis schizophrenia or Parkinson's disease; 4.cognitive disorder or hearing disorder; 5. BMI?32 kg/m; 6.drunk or drug allergy;7.severe hepatic dysfunction (Child-Pugh class C) severe renal dysfunction;8.benzodiazepines or propofol allergic history;9. left atrial or left atrial appendage thrombus; 10.pregnant; 11.attend other medcine in 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sedation recovery time; | — |
Secondary
| Measure | Time frame |
|---|---|
| hypotension;hypoxemia;sedation induction time; | — |
Countries
China
Contacts
Public ContactHuang Xinmiao
Department of Cardiovasology,Changhai Hospital,Naval Medical UniversityShanghai
Outcome results
None listed